Overview
Philip Morris International Inc. is a leading tobacco company headquartered in New York, USA, with a robust global presence. The company primarily operates in the manufacture and sale of cigarettes and smoke-free products, including heated tobacco and nicotine-containing vapor products. A key focus for Philip Morris International is its "smoke-free future" initiative, aimed at transitioning adult smokers to less harmful alternatives to cigarettes. This is epitomized by their significant investment in research, development, and marketing of Reduced-Risk Products (RRPs), highlighted by their IQOS heat-not-burn technology. The company maintains a widespread international market, supporting its operations through strategic production and distribution channels across numerous countries.
AI+ Ask Fintel’s AI assistant about Philip Morris International Inc..
Thinking about good questions…
Basic Stats
The Factor Analysis chart (below right) shows a view of Philip Morris International Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 1,557.37 MM |
| Earnings Date | |
| EPS (TTM) | |
| Dividend Yield | |
| Ex-Dividend Date | 2025-06-27 |
| Borrow Rate | |
| Short Shares Avail. | 0.00 MM |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | |
| ROE | |
| ROIC | |
| CROIC | |
| OCROIC | |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 0.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Philip Morris International Inc. is MX$1,752.08. The forecasts range from a low of MX$1,362.27 to a high of MX$2,206.68. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Philip Morris International Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2025-07-30 | Barclays | Overweight | Overweight | Maintains |
| 2024-09-04 | Stifel | Buy | Buy | Maintains |
| 2024-09-04 | B of A Securities | Buy | Buy | Maintains |
| 2024-09-09 | UBS | Sell | Sell | Maintains |
| 2024-09-09 | Barclays | Overweight | Overweight | Maintains |
| 2025-07-23 | Needham | Buy | Buy | Reiterate |
| 2025-04-25 | UBS | Sell | Neutral | Upgrade |
| 2025-04-24 | Stifel | Buy | Buy | Maintains |
| 2025-04-24 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-07-25 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-07-24 | Stifel | Buy | Buy | Maintains |
| 2024-07-24 | B of A Securities | Buy | Buy | Maintains |
| 2025-02-07 | UBS | Sell | Sell | Maintains |
| 2025-02-07 | Stifel | Buy | Buy | Maintains |
| 2025-07-09 | Jefferies | Buy | Initiate | |
| 2024-09-26 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-10-15 | UBS | Sell | Sell | Maintains |
| 2024-10-23 | UBS | Sell | Sell | Maintains |
| 2024-10-23 | Stifel | Buy | Buy | Reiterate |
| 2024-10-23 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-08-14 | Barclays | Overweight | Overweight | Maintains |
| 2024-07-25 | Deutsche Bank | Buy | Buy | Maintains |
| 2024-04-24 | Stifel | Buy | Buy | Maintains |
| 2024-03-05 | Argus Research | Buy | Hold | Downgrade |
| 2024-02-13 | Societe Generale | Sell | Hold | Upgrade |
| 2024-01-23 | UBS | Buy | Sell | Downgrade |
| 2023-11-29 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-11-16 | Redburn Atlantic | Neutral | Initiate | |
| 2023-10-13 | Jefferies | Buy | Buy | Maintains |
| 2023-10-05 | UBS | Buy | Buy | Maintains |
| 2023-10-02 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-10-02 | Stifel | Buy | Buy | Reiterate |
| 2023-09-21 | Barclays | Overweight | Overweight | Maintains |
| 2023-08-22 | Jefferies | Buy | Buy | Maintains |
| 2023-06-27 | Morgan Stanley | Overweight | Overweight | Reiterate |
| 2023-06-20 | Citigroup | Neutral | Buy | Upgrade |
| 2023-04-14 | Stifel | Buy | Reiterate | |
| 2023-04-13 | Stifel | Buy | Reiterate | |
| 2023-03-30 | JP Morgan | Neutral | Overweight | Upgrade |
| 2023-03-01 | UBS | Neutral | Buy | Upgrade |
| 2023-02-13 | JP Morgan | Neutral | Maintains | |
| 2023-02-02 | Morgan Stanley | Overweight | Maintains | |
| 2023-01-25 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2023-01-19 | Jefferies | Hold | Buy | Upgrade |
| 2022-12-13 | Citigroup | Neutral | Reiterate | |
| 2022-11-15 | Argus Research | Hold | Buy | Upgrade |
| 2022-11-02 | Morgan Stanley | Overweight | Maintains | |
| 2022-10-14 | Stifel | Buy | Maintains | |
| 2022-10-14 | Morgan Stanley | Overweight | Maintains | |
| 2022-07-19 | Jefferies | Hold | Maintains | |
| 2022-04-22 | Morgan Stanley | Overweight | Maintains | |
| 2022-03-25 | Morgan Stanley | Overweight | Maintains | |
| 2022-03-25 | Stifel | Buy | Maintains | |
| 2022-03-22 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2022-03-07 | JP Morgan | Overweight | Neutral | Downgrade |
| 2022-02-17 | UBS | Neutral | Maintains | |
| 2022-01-26 | Morgan Stanley | Overweight | Maintains | |
| 2021-12-02 | Morgan Stanley | Overweight | Maintains | |
| 2021-08-19 | Deutsche Bank | Buy | Maintains | |
| 2021-05-06 | Morgan Stanley | Overweight | Maintains | |
| 2021-04-21 | Morgan Stanley | Overweight | Maintains | |
| 2021-04-09 | JP Morgan | Neutral | Overweight | Upgrade |
| 2021-02-25 | Morgan Stanley | Overweight | Maintains | |
| 2021-01-20 | Bernstein | Market Perform | Initiate | |
| 2020-11-23 | UBS | Buy | Neutral | Downgrade |
| 2020-10-07 | Citigroup | Neutral | Buy | Upgrade |
| 2020-09-11 | B of A Securities | Buy | Maintains | |
| 2020-04-29 | UBS | Buy | Maintains | |
| 2020-04-07 | Citigroup | Neutral | Maintains | |
| 2020-04-01 | Goldman Sachs | Buy | Reiterate | |
| 2020-03-18 | Morgan Stanley | Overweight | Maintains | |
| 2020-02-13 | Cowen & Co. | Market Perform | Outperform | Upgrade |
| 2020-02-06 | CFRA | Buy | Reiterate | |
| 2020-01-07 | Piper Sandler | Overweight | Maintains | |
| 2019-12-16 | Morgan Stanley | Overweight | Maintains | |
| 2019-12-02 | Citigroup | Buy | Neutral | Downgrade |
| 2019-10-18 | Wells Fargo | Outperform | Maintains | |
| 2019-10-14 | Citigroup | Buy | Maintains | |
| 2019-10-01 | Bank of America | Neutral | Buy | Upgrade |
| 2019-07-19 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2019-07-12 | Morgan Stanley | Overweight | Maintains | |
| 2019-05-23 | Barclays | Underweight | Equal-Weight | Upgrade |
| 2019-05-17 | Bank of America | Underperform | Neutral | Upgrade |
| 2019-04-15 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2019-02-27 | UBS | Neutral | Buy | Upgrade |
| 2019-01-08 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-12-18 | Credit Suisse | Neutral | Underperform | Downgrade |
| 2018-10-19 | Citigroup | Buy | Buy | Maintains |
| 2018-10-16 | Bernstein | Outperform | Initiate | |
| 2018-09-21 | Citigroup | Buy | Buy | Maintains |
| 2018-08-24 | Jefferies | Buy | Hold | Downgrade |
| 2018-07-25 | Argus | Hold | Buy | Upgrade |
| 2018-07-20 | JP Morgan | Overweight | Neutral | Downgrade |
| 2018-07-20 | Citigroup | Buy | Buy | Maintains |
| 2018-07-20 | Stifel Nicolaus | Buy | Buy | Maintains |
| 2018-07-20 | Cowen & Co. | Outperform | Market Perform | Downgrade |
| 2018-07-17 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-04-24 | Deutsche Bank | Buy | Buy | Maintains |
| 2018-04-20 | Bank of America | Neutral | Underperform | Downgrade |
| 2018-04-20 | Stifel Nicolaus | Buy | Buy | Maintains |
| 2018-04-10 | Deutsche Bank | Buy | Initiate | |
| 2018-02-28 | Citigroup | Neutral | Buy | Upgrade |
| 2018-02-09 | Bank of America | Neutral | Neutral | Maintains |
| 2018-01-30 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-01-19 | Jefferies | Hold | Buy | Upgrade |
| 2017-11-15 | Wells Fargo | Outperform | Maintains | |
| 2017-10-20 | Societe Generale | Hold | Buy | Upgrade |
| 2017-10-20 | Citigroup | Neutral | Maintains | |
| 2017-10-20 | Bank of America | Neutral | Maintains | |
| 2017-08-11 | SBG Securities | Sell | Hold | Upgrade |
| 2017-07-10 | Bank of America | Neutral | Maintains | |
| 2017-05-25 | PiperJaffray | Overweight | Initiate | |
| 2017-01-04 | Bank of America | Buy | Neutral | Downgrade |
| 2016-11-14 | CLSA | Outperform | Buy | Upgrade |
| 2016-10-05 | Jefferies | Hold | Maintains | |
| 2016-10-04 | CLSA | Outperform | Maintains | |
| 2016-10-03 | Goldman Sachs | Buy | Maintains | |
| 2016-09-13 | Citigroup | Neutral | Initiate | |
| 2016-09-12 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2016-07-20 | SBG Securities | Sell | Hold | Upgrade |
| 2016-06-17 | JP Morgan | Neutral | Overweight | Upgrade |
| 2016-04-21 | Societe Generale | Sell | Hold | Upgrade |
| 2016-04-20 | Goldman Sachs | Neutral | Maintains | |
| 2016-04-19 | JP Morgan | Neutral | Maintains | |
| 2016-04-07 | Credit Suisse | Neutral | Maintains | |
| 2016-03-24 | Bank of America | Neutral | Buy | Upgrade |
| 2016-03-08 | Exane BNP Paribas | Neutral | Outperform | Upgrade |
| 2015-11-30 | Nomura | Reduce | Neutral | Upgrade |
| 2015-10-16 | Barclays | Overweight | Maintains | |
| 2015-05-13 | JP Morgan | Neutral | Initiate | |
| 2015-05-12 | JP Morgan | Neutral | Initiate | |
| 2015-05-08 | Goldman Sachs | Sell | Neutral | Upgrade |
| 2015-05-06 | CLSA | Underperform | Outperform | Upgrade |
| 2015-04-17 | Barclays | Overweight | Maintains | |
| 2015-04-17 | Cowen & Co. | Market Perform | Outperform | Upgrade |
| 2015-04-16 | Cowen & Co. | Market Perform | Outperform | Upgrade |
| 2015-04-13 | Argus | Buy | Hold | Downgrade |
| 2015-01-15 | Goldman Sachs | Neutral | Sell | Downgrade |
| 2014-12-08 | Nomura | Neutral | Reduce | Downgrade |
| 2014-09-26 | Bank of America | Buy | Neutral | Downgrade |
| 2014-07-11 | Cowen & Co. | Market Perform | Initiate | |
| 2014-07-09 | UBS | Neutral | Maintains | |
| 2014-04-24 | Nomura | Neutral | Maintains | |
| 2014-04-23 | UBS | Neutral | Maintains | |
| 2014-04-09 | Nomura | Reduce | Neutral | Upgrade |
| 2014-04-08 | Nomura | Reduce | Neutral | Upgrade |
| 2014-02-21 | FirstEnergy Capital | Outperform | Market Perform | Downgrade |
| 2014-02-20 | FirstEnergy Capital | Outperform | Market Perform | Downgrade |
| 2014-01-30 | Societe Generale | Sell | Initiate | |
| 2014-01-24 | Citigroup | Neutral | Maintains | |
| 2014-01-16 | Exane BNP Paribas | Neutral | Initiate | |
| 2014-01-06 | Standpoint Research | Sell | Initiate | |
| 2013-12-23 | FirstEnergy Capital | Outperform | Initiate | |
| 2013-11-26 | Stifel Nicolaus | Buy | Maintains | |
| 2013-11-21 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2013-11-21 | Jefferies | Hold | Maintains | |
| 2013-11-21 | Barclays | Overweight | Maintains | |
| 2013-10-10 | Nomura | Neutral | Reduce | Downgrade |
| 2013-09-03 | Stifel Nicolaus | Buy | Maintains | |
| 2013-04-19 | Nomura | Neutral | Maintains | |
| 2013-04-19 | Stifel Nicolaus | Buy | Maintains | |
| 2013-02-19 | Jefferies | Hold | Maintains | |
| 2013-02-13 | Nomura | Reduce | Neutral | Upgrade |
| 2013-01-11 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2012-10-19 | Jefferies | Hold | Maintains | |
| 2012-10-12 | Deutsche Bank | Buy | Maintains | |
| 2012-10-03 | Citigroup | Neutral | Maintains | |
| 2012-07-23 | Jefferies | Hold | Maintains | |
| 2012-04-19 | Citigroup | Neutral | Maintains | |
| 2012-04-13 | Stifel Nicolaus | Buy | Maintains | |
| 2024-10-01 | Deutsche Bank | Buy | Buy | Maintains |
| 2024-10-08 | Citigroup | Buy | Buy | Maintains |
| 2025-04-10 | Stifel | Buy | Buy | Maintains |
| 2025-02-26 | Barclays | Overweight | Overweight | Maintains |
| 2025-05-02 | Barclays | Overweight | Overweight | Maintains |
| 2025-07-10 | Citigroup | Buy | Buy | Maintains |
| 2025-01-16 | Morgan Stanley | Overweight | Initiate | |
| 2025-04-16 | Citigroup | Buy | Buy | Maintains |
| 2025-01-08 | Barclays | Overweight | Overweight | Maintains |
| 2024-10-30 | Barclays | Overweight | Overweight | Maintains |
| 2025-02-18 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-07-10 | Barclays | Overweight | Overweight | Maintains |
| 2025-07-10 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-05-22 | Needham | Buy | Initiate | |
| 2025-06-13 | Barclays | Overweight | Overweight | Maintains |
| 2025-06-04 | B of A Securities | Buy | Buy | Maintains |
| 2025-07-14 | UBS | Neutral | Neutral | Maintains |
| 2025-09-05 | UBS | Neutral | Neutral | Maintains |
